421 related articles for article (PubMed ID: 14566013)
1. Perlecan and tumor angiogenesis.
Jiang X; Couchman JR
J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
[TBL] [Abstract][Full Text] [Related]
2. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
3. Novel interactions of perlecan: unraveling perlecan's role in angiogenesis.
Bix G; Iozzo RV
Microsc Res Tech; 2008 May; 71(5):339-48. PubMed ID: 18300285
[TBL] [Abstract][Full Text] [Related]
4. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
Aviezer D; Hecht D; Safran M; Eisinger M; David G; Yayon A
Cell; 1994 Dec; 79(6):1005-13. PubMed ID: 7528102
[TBL] [Abstract][Full Text] [Related]
5. Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis.
Jiang X; Multhaupt H; Chan E; Schaefer L; Schaefer RM; Couchman JR
J Histochem Cytochem; 2004 Dec; 52(12):1575-90. PubMed ID: 15557212
[TBL] [Abstract][Full Text] [Related]
6. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
7. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
8. Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.
Iozzo RV; Zoeller JJ; Nyström A
Mol Cells; 2009 May; 27(5):503-13. PubMed ID: 19466598
[TBL] [Abstract][Full Text] [Related]
9. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
10. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
[TBL] [Abstract][Full Text] [Related]
11. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
12. Diverse cell signaling events modulated by perlecan.
Whitelock JM; Melrose J; Iozzo RV
Biochemistry; 2008 Oct; 47(43):11174-83. PubMed ID: 18826258
[TBL] [Abstract][Full Text] [Related]
13. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
14. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
Larraín J; Alvarez J; Hassell JR; Brandan E
Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
[TBL] [Abstract][Full Text] [Related]
15. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.
Melrose J; Smith MM; Smith SM; Ravi V; Young AA; Dart AJ; Sonnabend DH; Little CB
Tissue Cell; 2013 Feb; 45(1):77-82. PubMed ID: 23245384
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
[TBL] [Abstract][Full Text] [Related]
17. The role of perlecan in arterial injury and angiogenesis.
Segev A; Nili N; Strauss BH
Cardiovasc Res; 2004 Sep; 63(4):603-10. PubMed ID: 15306215
[TBL] [Abstract][Full Text] [Related]
18. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Sharma B; Handler M; Eichstetter I; Whitelock JM; Nugent MA; Iozzo RV
J Clin Invest; 1998 Oct; 102(8):1599-608. PubMed ID: 9788974
[TBL] [Abstract][Full Text] [Related]
19. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
